中文版 | English

在结果中检索

CASIA OpenIR

浏览/检索结果: 共4条，第1-4条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
A Hepatocellular Carcinoma Targeting Nanostrategy with Hypoxia-Ameliorating and Photothermal Abilities that, Combined with Immunotherapy, Inhibits Metastasis and Recurrence 期刊论文
ACS NANO, 2020, 卷号: 14, 期号: 10, 页码: 12679-12696
作者:  Zhou, Tianjun;  Liang, Xiaolong;  Wang, Peifeng;  Hu, Yueyang;  Qi, Yafei;  Jin, Yushen;  Du, Yang;  Fang, Chihua;  Tian, Jie
收藏  |  浏览/下载：176/0  |  提交时间：2021/03/02
hepatocellular carcinoma  prussian blue  photothermal therapy  sorafenib  hypoxia  antiprogrammed death-ligand I  immunotherapy  
MRI-Based Deep-Learning Model for Distant Metastasis-Free Survival in Locoregionally Advanced Nasopharyngeal Carcinoma 期刊论文
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2020, 页码: 12
作者:  Zhang, Lu;  Wu, Xiangjun;  Liu, Jing;  Zhang, Bin;  Mo, Xiaokai;  Chen, Qiuying;  Fang, Jin;  Wang, Fei;  Li, Minmin;  Chen, Zhuozhi;  Liu, Shuyi;  Chen, Luyan;  You, Jingjing;  Jin, Zhe;  Tang, Binghang;  Dong, Di;  Zhang, Shuixing
收藏  |  浏览/下载：181/0  |  提交时间：2020/09/07
nasopharyngeal carcinoma  deep learning  distant metastasis-free survival  induction chemotherapy  chemoradiotherapy  
Development of a Deep Learning Model to Identify Lymph Node Metastasis on Magnetic Resonance Imaging in Patients With Cervical Cancer 期刊论文
JAMA NETWORK OPEN, 2020, 卷号: 3, 期号: 7, 页码: 13
作者:  Wu, Qingxia;  Wang, Shuo;  Zhang, Shuixing;  Wang, Meiyun;  Ding, Yingying;  Fang, Jin;  Qian, Wei;  Liu, Zhenyu;  Sun, Kai;  Jin, Yan;  Ma, He;  Tian, Jie
收藏  |  浏览/下载：247/0  |  提交时间：2020/09/07
Association of MRI-derived radiomic biomarker with disease-free survival in patients with early-stage cervical cancer 期刊论文
THERANOSTICS, 2020, 卷号: 10, 期号: 5, 页码: 2284-2292
作者:  Fang, Jin;  Zhang, Bin;  Wang, Shuo;  Jin, Yan;  Wang, Fei;  Ding, Yingying;  Chen, Qiuying;  Chen, Liting;  Li, Yueyue;  Li, Minmin;  Chen, Zhuozhi;  Liu, Lizhi;  Liu, Zhenyu;  Tian, Jie;  Zhang, Shuixing
收藏  |  浏览/下载：296/0  |  提交时间：2020/03/30
cervical cancer  magnetic resonance imaging  radiomics  disease-free survival